European Annals of Otorhinolaryngology-Head and Neck Diseases最新文献_第3页

Comparison of two quality-of-life questionnaires in cochlear implanted children 人工耳蜗植入儿童两种生活质量问卷的比较。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2025-10-22 DOI: 10.1016/j.anorl.2025.10.006

C. Chandrakumar, F.-X. Bétolaud, N. Noël-Petroff, T. Deray, T. Van Den Abbeele, E. Bois

引用次数: 0

Pulsatile tinnitus with pulsatile tympanic membrane without retrotympanic mass: A CARE case report 搏动性耳鸣伴鼓膜搏动性耳鸣，鼓膜后无肿块1例。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-06 DOI: 10.1016/j.anorl.2026.01.002

D. Moreau , O. Heck , S. Schmerber , R. Quatre

引用次数: 0

Unilateral epistaxis and nasal obstruction in a middle-aged woman 中年妇女单侧鼻出血及鼻塞一例。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-04 DOI: 10.1016/j.anorl.2025.12.002

S. Moon , E. Shin , J.W. Kang

引用次数: 0

Oncologic and functional perspectives in cT2N0M0 glottic SCC: A critical appraisal of SCPL-CHEP versus CO2 laser cordectomy cT2N0M0声门鳞状细胞癌的肿瘤学和功能观点：对scl - chep与CO2激光切除的关键评价。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2025-10-10 DOI: 10.1016/j.anorl.2025.09.005

P. Aphale , S. Dokania , H. Shekhar

引用次数: 0

Total maxillectomy with free scapula tip flap reconstruction: Airway management, aesthetic and functional results 上颌全切除术与自由肩胛骨尖瓣重建：气道管理，美学和功能的结果

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2025-10-24 DOI: 10.1016/j.anorl.2025.08.006

C. Sayah , E. Bertin , P. Philouze , P. Céruse , C. Fuchsmann

{"title":"Total maxillectomy with free scapula tip flap reconstruction: Airway management, aesthetic and functional results","authors":"C. Sayah , E. Bertin , P. Philouze , P. Céruse , C. Fuchsmann","doi":"10.1016/j.anorl.2025.08.006","DOIUrl":"10.1016/j.anorl.2025.08.006","url":null,"abstract":"<div><h3>Aim</h3><div>Airway management and evaluation of functional and aesthetic results after total maxillectomy and chimeric osteo-musculo-cutaneous scapula tip flap reconstruction without tracheotomy.</div></div><div><h3>Materials and methods</h3><div>A single-center retrospective study of patients with malignant or benign maxillary bone or sinus tumors managed by total maxillectomy and free scapula tip flap reconstruction between January 2015 and July 2023 was performed. Data collected allowed postoperative airway management analysis. The EORTC QLQ-C30 and H&N43 questionnaires, DASH, UW-QOL-V4 and the FOIS scale were used for functional and aesthetic assessments.</div></div><div><h3>Objectives</h3><div>Analyze the perioperative data of patients operated on. Secondary objective was to evaluate functional and aesthetic results.</div></div><div><h3>Results</h3><div>Sixteen patients underwent total maxillectomy with scapula tip free flap reconstruction during the study period. Twelve (75%) patients spent an average of one day in the intensive care unit (ICU), 12 patients (75%) were extubated immediately at the end of surgery, the remaining 4 patients were extubated on day 1. No patient required re-intubation or tracheotomy. The pulmonary complication rate was low (6.2%). The mean time to resumption of feeding was 7.3 (±1.8) days, and the mean hospital stay was 14 (±3.8) days. Functional analysis was performed on 11 patients. More than half the patients had a normal diet. No patients limited their activities because of their appearance.</div></div><div><h3>Conclusion</h3><div>This series shows that it is possible to perform this surgery without systematic tracheotomy. A good aesthetic result and satisfactory recovery of functional and swallowing abilities is possible.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 2","pages":"Pages 99-106"},"PeriodicalIF":2.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147551277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Extensive upper aerodigestive tract involvement in metamizole-induced Stevens-Johnson syndrome/toxic epidermal necrolysis metamizle诱导的Stevens-Johnson综合征/中毒性表皮坏死松解广泛累及上呼吸道消化道。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2025-10-10 DOI: 10.1016/j.anorl.2025.09.007

A.D. Asimakopoulos , S. Bouayed

引用次数: 0

The dynamism of the French Expert Network on Rare ENT Cancers (REFCOR) 法国罕见耳鼻喉癌专家网络（REFCOR）的活力。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-19 DOI: 10.1016/j.anorl.2026.02.001

L. de Gabory

引用次数: 0

REFCOR guidelines for sinus and nasal cavity cancer 鼻窦和鼻腔癌的REFCOR指南。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-19 DOI: 10.1016/j.anorl.2026.02.002

C.-H. Hassan , A.-C. Baglin , B. Baujat , V. Coste-Martineau , G. de Bonnecaze , L. Digue , C. Dupin , C. Even , F.-R. Ferrand , C. Rumeau , J. Michel , A. Moya-Plana , T. Radulesco , J. Thariat , S. Vergez , B. Vérillaud , C. Monnot , L. de Gabory

{"title":"REFCOR guidelines for sinus and nasal cavity cancer","authors":"C.-H. Hassan , A.-C. Baglin , B. Baujat , V. Coste-Martineau , G. de Bonnecaze , L. Digue , C. Dupin , C. Even , F.-R. Ferrand , C. Rumeau , J. Michel , A. Moya-Plana , T. Radulesco , J. Thariat , S. Vergez , B. Vérillaud , C. Monnot , L. de Gabory","doi":"10.1016/j.anorl.2026.02.002","DOIUrl":"10.1016/j.anorl.2026.02.002","url":null,"abstract":"<div><h3>Introduction</h3><div>The first guidelines of the French Expertise Network on Rare ENT Cancers (REFCOR) on the management of nasal cavity and sinus cancer date back to 2009. The objective of the present study was to update these guidelines using a search of the literature between 2009 and 2020.</div></div><div><h3>Method</h3><div>The literature analysis was carried out using PRISMA criteria to enrich the previous literature review; 250 studies were selected out of 1696 analyzed. General considerations were formulated, common to all histologies and specific to each. The formalized expert consensus method was used to revise the old guidelines and propose new ones.</div></div><div><h3>Results</h3><div>The scientific analysis led to 87 recommendations: common to all sinonasal cancers (1 to 10), and for adenocarcinoma (11 to 28), adenoid cystic carcinoma (29 to 42), squamous cell carcinoma (43 to 53), mucosal melanoma (54 to 66), neuroblastoma (67 to 72) and undifferentiated carcinoma (73 to 87). According to first 10 guidelines, management of sinonasal cancer requires multidisciplinary teamwork, specifically trained teams and multidisciplinary tumor board meetings, and the emergence of new anatomopathological entities requires in-depth histological and immunophenotypic investigation.</div></div><div><h3>Conclusion</h3><div>The present article provides a short version of the updated review validating the first 10 guidelines for diagnostic and therapeutic action on general themes common to all histologies.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 2","pages":"Pages 107-114"},"PeriodicalIF":2.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146259872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Review of the literature on new histologic entities in sinonasal cancer 鼻窦癌新组织学实体的文献综述。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-16 DOI: 10.1016/j.anorl.2026.01.008

C. Lépine , C. Castain , A.-C. Baglin , V. Costes-Martineau

{"title":"Review of the literature on new histologic entities in sinonasal cancer","authors":"C. Lépine , C. Castain , A.-C. Baglin , V. Costes-Martineau","doi":"10.1016/j.anorl.2026.01.008","DOIUrl":"10.1016/j.anorl.2026.01.008","url":null,"abstract":"<div><div>The nasal cavities and sinuses are the site of many tumoral entities, which are increasingly well described, especially since the advent of molecular biology. The present systematic review collates the current state of knowledge on six new entities described in the 2017 and 2022 versions of the WHO classification of sinonasal tumors: <em>DEK::AFF2</em> rearranged squamous cell carcinoma, HPV-associated multiphenotypic sinonasal carcinoma, NUT carcinoma, <em>SMARCB1</em>-deficient and <em>SMARCA4</em>-deficient carcinoma, biphenotypic sinonasal sarcoma, and adamantinoma-like Ewing sarcoma. A systematic literature search was performed on PubMed. The inclusion criteria focused on English-language articles precisely describing the histologic, immunohistochemical, molecular, clinical and prognostic characteristics of these entities. It is essential to be able to identify these entities, as they have distinct profiles in terms of progression and prognosis compared to other sinonasal tumors. The present study exhaustively describes their clinical and pathologic characteristics.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 2","pages":"Pages 115-122"},"PeriodicalIF":2.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146214720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

REFCOR good practice guidelines for radiotherapy in sinonasal carcinomas and mucosal melanomas 鼻窦癌和粘膜黑色素瘤放疗的REFCOR良好实践指南。

IF 2.4 4区医学

European Annals of Otorhinolaryngology-Head and Neck Diseases Pub Date : 2026-03-01 Epub Date: 2026-02-23 DOI: 10.1016/j.anorl.2026.02.003

J. Thariat , C. Dupin , L. de Gabory , REFCOR network

{"title":"REFCOR good practice guidelines for radiotherapy in sinonasal carcinomas and mucosal melanomas","authors":"J. Thariat , C. Dupin , L. de Gabory , REFCOR network","doi":"10.1016/j.anorl.2026.02.003","DOIUrl":"10.1016/j.anorl.2026.02.003","url":null,"abstract":"<div><h3>Introduction</h3><div>The present REFCOR guidelines define indications for radiotherapy in sinonasal carcinoma and mucosal melanoma.</div></div><div><h3>Methods</h3><div>They result from multidisciplinary consensus based on a critical review of the literature, feedback from expert centers, and a structured process to harmonize clinical practice across France.</div></div><div><h3>Results</h3><div>Indications for radiotherapy are determined by tumor-specific characteristics and histoprognostic factors. In France, treatment decisions for these tumors are discussed in regional or national REFCOR expert panel multidisciplinary tumor boards. Radiotherapy is most often adjuvant, delivered at a short postsurgical interval, but can be exclusive for unresectable tumors or when surgery is contraindicated. It should be performed by experienced teams. The timing of postoperative treatment and the tumoral and nodal targets are tailored to histology and disease stage; their definition is based on a comprehensive and accurate characterization of surgical specimens, including multibloc resections obtained through open or endoscopic endonasal approaches. Given the anatomical proximity of the paranasal sinuses to highly radiosensitive structures (neurological, optic, otologic, and mucosal), technique and quality are critical for achieving tumor control while minimizing morbidity. Conformal techniques such as IMRT or VMAT represent the current gold standard. Proton therapy may be considered to improve sparing of organs at risk.</div></div><div><h3>Conclusion</h3><div>The REFCOR guidelines establish a framework for indications for precision radiotherapy within a multidisciplinary patient-centered approach adapted to individual tumor characteristics. For each patient, recommendations are complemented by REFCOR multidisciplinary tumor board discussion in a personalized care pathway.</div></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":"143 2","pages":"Pages 123-127"},"PeriodicalIF":2.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147285888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0